Detrimental effect of a non-selective nitric oxide synthase inhibitor on the energy state of the liver following acute endotoxemia in rabbits

Acta Anaesthesiologica Scandinavica

Volumn 42, Issue 4, 1998, Pages 399-405

  Kaneda, K ^a   Makita, K ^a   Yokoyama, K ^a   Toyooka, H ^b   Amaha, K ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Endotoxic shock; Hemodynamics; Lipopolysaccharide; Liver energetics; Magnetic resonance; Nitric oxide; Nitric oxide inhibitor; Rabbit

Indexed keywords

ADENOSINE TRIPHOSPHATE; LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENERGY TRANSFER; ENZYME ACTIVITY; HEART OUTPUT; INTRAVENOUS DRUG ADMINISTRATION; LIVER FUNCTION; LUNG CIRCULATION; LUNG VASCULAR RESISTANCE; MEAN ARTERIAL PRESSURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RABBIT; SEPTIC SHOCK;

EID: 0031884296     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1998.tb05132.x     Document Type: Article

References (24)

1. Wolfe TA, Dasta JF. Use of nitric oxide synthase inhibitors as a novel treatment for septic shock. Ann Pharmacother 1995: 29: 36-46.
2. Szabo C. Alterations in nitric oxide production in various forms of circulatory shock. New Horiz 1995: 3: 2-32.
3. Meyer J, Booke M, Waurick R et al. Nitric oxide synthase inhibition restores vasopressor effects of norepinephrine in ovine hyperdynamic sepsis. Anesth Analg 1996: 83: 1009-1013.
4. Traber DL. Presence and absence of nitric oxide synthase in sepsis. Crit Care Med 1996: 24: 1102-1103.
5. Robertson FM, Offner PJ, Ciceri DP et al. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 1994: 129: 149-156.
6. Fukatsu K, Saito H, Fukushima R et al. Deterimental effects of a nitric oxide synthase inhibitor (N-ω-nitro-L-arginine-methyl-ester) in a murine sepsis model. Arch Surg 1995: 130: 410-414.
7. Cobb JP, Danner RL. Nitric oxide and septic shock. JAMA 1996: 275: 1192-1196.
8. Harbrecht BG, Billiar TR, Stadler J et al. Inhibition of nitric oxide synthesis during endotoxcemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J Leukoc Biol 1992: 52: 390-394.
9. Harbrecht BG, Billiar TR, Stadler J et al. Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia. Crit Care Med 1992: 20: 1568-1574.
10. Nishida J, Mccuskey RS, Mcdonnell D et al. Protective role of NO in hepatic microcirculatory dysfunction during endotoxemia. Am J Physiol 1994: 267: C1135-1141.
11. Wright CE, Rees DD, Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992: 26: 48-57.
12. Pastor C, Teisseire B, Vicaut E, Payen M. Effects of L-arginine treatment on blood pressure and cardiac output in a rabbit endotoxin shock model. Crit Care Med 1994: 22: 465-469.
13. Pastor CM, Losser MR, Payen DM. Nitric oxide donor prevents hepatic and systemic perfusion decrease induced by endotoxin in anesthetized rabbits. Hepatology 1995: 22: 1547-1553.
14. Pastor CM, Payen DM. Effect of modifying nitric oxide pathway on liver circulation in a rabbit endotoxin shock model. Shock 1994: 2: 196-202.
15. Weiner MW. NMR Spectroscopy for clinical medicine animal models and clinical examples. Ann N Y Acad Sci 1987: 508: 287-299.
16. 31P- and 1 H-magnetic resonance spectroscopic study. Crit Care Med 1997: 25: 1019-1029.
17. Uchida T, Ichikawa K, Yokoyama K et al. Inhaled nitric oxide improved the outcome of severe right ventricular failure caused by lipopolysaccharide administration. Intensive Care Med 1996: 22: 1203-1206.
18. Liaudet L, Rosselet A, Perret C et al. Beneficial effects of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, during rodent endotoxaemia. Clin Sci 1996: 90: 369-377.
19. Aranow JS, Wang H, Zhuang J et al. A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: Comparison with two non-selective strategies. Shock 1996: 5: 116-121.
20. Wu CC, Chen SJ, Szabo C et al. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol 1995: 114: 1666-1672.
21. Yokoyama T, Okamoto R, Ozawa K et al. Hepatic energy status in hypotension of different aetiologies in dogs. Clin Sci 1991: 81: 627-633.
22. Mizutani T, Layon AJ. Clinical applications of nitric oxide. Chest 1996: 110: 506-524.
23. Bone HG, Traber DL. Nitric oxide inhibition in the treatment of septic shock. Crit Care Med 1996: 24: 1422.
24. Booke M, Meyer J, Lingnau W et al. Use of nitric oxide inhibitors in animal models of sepsis. New Horiz 1995: 3: 123-138.